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The aim of this study was to evaluate the gastroprotective activity of ethanolic extract of geopropolis (EEGP) from Melipona
scutellaris and to investigate the possible mechanisms of action. The gastroprotective activity of the EEGP was evaluated using
model ulcer induced by ethanol. To elucidate the possible mechanisms of action, we investigated the involvement of the nonprotein
sulfhydryl (NP-SH) groups, nitric oxide and prostaglandins. In addition, the antisecretory activity of EEGP was also evaluated by
pylorus ligatedmodel.TheEEGPorally administrated (300mg/kg) reduced the ulcerative lesions induced by the ethanol (𝑃 < 0.05).
Regarding the mechanism of action, the prior administration of nitric oxide and prostaglandins antagonists suppressed the activity
of gastroprotective EEGP (𝑃 < 0.05). On the other hand the gastroprotective activity of EEGPwas kept in the group pretreated with
the antagonist of the NP-SH groups; furthermore the antisecretory activity was not significant (𝑃 > 0.05). These results support
the alternative medicine use of geopropolis as gastroprotective and the activities observed show to be related to nitric oxide and
prostaglandins production.
1. Introduction
Peptic ulcers are the imbalance between the aggressive agents
(Helicobacter pylori and anti-inflammatory drugs, among
others) and the protective agents (prostaglandins and nitric
oxide, among others) [1, 2]. Despite the widespread use of
different classes of monodrugs for the treatment of different
types of ulcers, a large part of the world’s population still
benefits from the use of natural products [3].
The propolis is a nontoxic natural product, collected by
bees from different plant parts [4]. Propolis has increased in
popularity as an alternative medicine or dietary supplement,
for improving health and preventing disease in various parts
of the world [5]. Among the several biological activities
of propolis reported in the literature antimicrobial, anti-
inflammatory, anticancer, laxative, and antiulcer can be found
[6–10].
The geopropolis, a mixture of resin, wax, and soil, is a
propolis collected by a native stingless bee of the Meliponini
tribe [11, 12] and also widely used in folk medicine for various
therapeutic purposes [5].
The geopropolis from Melipona scutellaris bee species,
popularly known as “uruc¸u” and found in northeastern
Brazil, has been the focus of our research. Studies have shown
that geopropolis has antinociceptive and anti-inflammatory
properties, besides antimicrobial activity against different
types of bacteria. In addition, studies on the chemical profile
of geopropolis revealed absence of flavonoid and phenolic
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acids commonly found in propolis from Apis mellifera and
presence of benzophenones [13–16].
Therefore, in order to aggregate scientific value to the
geopropolis, this study aims at evaluating the gastroprotective
activity of the ethanolic extract of geopropolis (EEGP) from
Melipona scutellaris and at investigating the possible mecha-
nisms of action.
2. Material and Methods
2.1. Obtaining the EEGP. The geopropolis samples were
collected on municipality of Entre Rios (11∘57󸀠 S, 38∘05󸀠 W),
state of Bahia, northeast of Brazil. The geopropolis samples
(100 g) were extracted in 80% ethanol in water (w/v) at a 1/7
dilution rate at 70∘C for 30min, followed by filtration, thereby
obtaining the EEGP.The same process was repeated twice. At
the end, the EEGP was concentrated in a rotary evaporator at
40∘C [13].TheEEGPdissolutionwas carried out in PBS 1mM.
The EEGP was administered to the animals by pathway oral
(p.o.).
2.2. Animals. MaleWistar rats, SPF (specific-pathogen-free),
weighing 200–250 g were provided by CEMIB/UNICAMP
(Multidisciplinary Center for Biological Research, SP, Brazil)
and kept in controlled temperature chambers (20 ± 2∘C)
in light-dark 12 hours cycles, relative humidity of 40 and
60%, with filtered water ad libitum. The animals fasted for
24 hours before the experiments. The procedures described
were reviewed and approved by the local Animal Ethics
Committee (CEUA Unicamp process number 2560-1).
2.3. Drugs and Reagents. The drugs were purchased from
Sigma Chemical Co. St. Louis, MO, USA (N-ethylmaleimide,
omeprazole, N𝜔-nitro-L-arginine methyl ester hydrochlo-
ride, and ethanol), MP Biomedicals (indomethacin), and
Merck (organic solvents).
2.4. Gastric Lesion Induced by Ethanol. The rats were pre-
treated with EEGP at dose of 100, 200, or 300mg/kg (p.o.).
The positive control group received omeprazole 30mg/kg
(p.o.), and the negative control group received dissolving
vehicle of EEGP (p.o.). One hour after the treatments, 1mL
of absolute ethanol was administered by p.o, and, one hour
later, the animals were killed by anesthesia overload, and
the stomach was removed and opened along the greater
curvature [17]. The ulcerative lesions from each animal were
calculated according to the Gamberini et al. [18] method, as
described below.
2.5. Role of the Nonprotein Sulfhydryl (NP-SH) Groups on
Gastroprotection Effect of the EEGP. The rats were pretreated
with inhibitor of the NP-SH groups (N-ethylmaleimide
10mg/kg, s.c.), 30min prior to the treatment with EEGP
(300mg/kg) by p.o. [19]. The negative control group received
dissolution vehicle of EEGP (p.o.). One hour after the treat-
ments, 1mLof absolute ethanolwas administered by p.o., and,
one hour later, the animals were killed by anesthesia overload,
and the stomach was removed and opened along the greater
curvature. The ulcerative lesions from each animal were
calculated according to the Gamberini et al. [18] method.
2.6. Role of the Nitric Oxide on Gastroprotective Effect of the
EEGP. Therats were pretreatedwith inhibitor from the nitric
oxide synthase (L-NAME 5mg/kg) by intraperitoneal (i.p.)
administration, 30min prior to the treatment with EEGP
(300mg/kg, p.o.). The negative control group received disso-
lution vehicle of EEGP (p.o.). One hour after the treatments,
1mL of absolute ethanol was administered by p.o., and, one
hour later, the animals were killed by anesthesia overload,
and the stomach was removed and opened along the greater
curvature [19]. The ulcerative lesions from each animal were
calculated according to the Gamberini et al. [18] method.
2.7. Role of Prostaglandins on Gastroprotective Effect of the
EEGP. The rats were pretreated with the cyclooxygenase
inhibitor (indomethacin 5mg/kg, i.p.), 30min before the
EEGP treatment (300mg/kg, p.o.). The negative control
group received dissolution vehicle of EEGP (p.o.). One hour
after the treatments, 1mL of absolute ethanol was adminis-
tered by p.o., and, one hour later, the animals were killed
by anesthesia overload, and the stomach was removed and
opened along the greater curvature [19].Theulcerative lesions
fromeach animalwere calculated according to theGamberini
et al. [18] method.
2.8. Evaluation of the Antisecretory Activity. Theanimals were
anesthetized, their abdomen was dissected, and the pylorus
was connected. Immediately after this procedure, the EEGP
300mg/kg, cimetidine 100mg/kg, or dissolution vehicle of
EEGP (negative control) was administered by p.o. to the
respective group of animals. The abdomens were sutured
and, four hours later, the animals were killed. The stomachs
were removed and the gastric content was collected and
centrifuged. The volume and the pH of the gastric juice were
measured [20].
2.9. Statistical Analysis. Data were expressed as means ±
standard error of the mean (SEM) and statistical comparison
between groups was made utilizing analysis of variance
(ANOVA) followed by test of Dunnett or Tukey. Significance
was accepted when 𝑃 < 0.05.
3. Results and Discussion
This study evaluated the gastroprotective activity of EEGP
fromMelipona scutellaris, as well as the possible actionmech-
anisms involved.
The geopropolis used in this work presents the same
chemical composition as described in our previous publica-
tions, where absence of flavonoids and phenolic acids and
presence of benzophenone were found [15, 16].
Ethanol is a potent gastric ulcer inducer agent, and it
is widely applied to evaluate the gastroprotective activity
of plant extracts, as well as new pharmaceutical drugs
in animal models. Its effect causes an imbalance between
the oxidizing and the antioxidants agents in the gastric
Evidence-Based Complementary and Alternative Medicine 3
C Omep 30 100 200 300
0
10
20
30
40
50
(mg/kg, p.o.)
Treatments
EEGP
U
lc
er
at
iv
e l
es
io
n 
in
de
x
∗
∗
Figure 1: Effect of the p.o. administration of ethanolic extract of
geopropolis (EEGP) on the ethanol induced ulcers. Control (C)
treated with vehicle, omeprazole 30mg/kg (Omep 30), and EEGP
with doses of 100, 200, and 300mg/kg. The results are expressed
as means ± SEM, 𝑛 = 5. Symbols indicate statistical difference
(ANOVA followed by Dunnett test, 𝑃 < 0.05). ∗ compared to the
control group.
mucosa. This imbalance causes bleeding resulting from the
ruptured blood vessels [21, 22]. In the present study, we
evaluated the EEGP gastroprotective activity on the ethanol-
induced ulcermodel (Figure 1).TheEEGP (300mg/kg) orally
administrated decreased the ulcerative lesions, where an 89%
reduction was detected compared to the negative control
group (𝑃 < 0.05). Regarding the positive control group
(omeprazole), there was an 85% reduction of the ulcerative
lesions compared to the negative control group (𝑃 < 0.05).
To elucidate the possible mechanisms of action involved
with the gastroprotective activity of EEGP, we investigated
the participation of the NP-SH groups, nitric oxide and
prostaglandins. In addition, the antisecretory activity of
EEGP was also evaluated.
TheNP-SHgroups are protective of the gastricmucosa. In
this case, the role of thesemediators is associatedwith the free
radicals blockage in the gastric mucosa [23]. Thus, in order
to evaluate the EEGP association with these substances, the
animals underwent a pretreatment with a blocker agent (N-
ethylmaleimide 10mg/kg) of the NP-SH groups. The results
showed that the administration of the N-ethylmaleimide
(Figure 2) did not suppress the gastroprotective activity of the
EEGP (𝑃 > 0.05). Thus, suggesting that the EEGP activity is
not associated with NP-SH groups.
Nitric oxide plays a vital role in gastric gastroprotection
also. Among its actions are regulation of gastric secretion and
gastric stimulation of mucus secretion [24, 25]. Furthermore,
studies have shown thatNO is able to decrease the adhesion of
neutrophils to endothelial cells during the inflammatory pro-
cess [26]. The pretreatment with L-NAME (inhibitor of syn-
thesis of nitric oxide) suppressed the gastroprotective activity
of EEGP (Figure 3, 𝑃 < 0.05). These results corroborate
the study of Franchin et al. [14], where it was observed that
the administration of inhibitors of nitric oxide production
suppressed the anti-inflammatory activity of the EEGP. In the
same study, it was found that the activity of EEGP on the
inflammatory processwas related to the increased production
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Figure 2: Effect of the p.o. administration of ethanolic extract of
geopropolis (EEGP) on the ethanol induced ulcers. Rats pretreated
subcutaneous (s.c.) with the N-ethylmaleimide 10mg/kg (NEM).
After 30min, the rats were treated with vehicle (C and NEM) and
with 300mg/kg doses of EEGP. The results are expressed as means
± SEM, 𝑛 = 5. Symbols indicate statistical difference (ANOVA
followed by Tukey test, 𝑃 < 0.05). # compared to control (C) group
and ∗ compared to control group.
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Figure 3: Effect of the p.o. administration of ethanolic extract of
geopropolis (EEGP) on the ethanol induced ulcers. Rats pretreated
with 5mg/kg of the L-NAME (i.p.). After 30min, the rats were
treatedwith vehicle (C and L-NAME) and 300mg/kg doses of EEGP.
The results are expressed as means ± SEM, 𝑛 = 5. Symbols indicate
statistical difference (ANOVA followed by Tukey test, 𝑃 < 0.05). #
compared to control group; ∗ compared to control (C) group; ∗∗
compared to EEGP group.
of nitric oxide (verified by quantifying nitrite), which resulted
in decreased adhesion of neutrophils on endothelial cells.
Therefore, the EEGP increased the gastroprotective response
and reduced the ulcerogenic effect induced by ethanol in the
gastric mucosa, probably by increased production of NO.
This study also evaluated the role of prostaglandins in
the EEGP gastroprotective activity. Indomethacin, a nons-
teroidal anti-inflammatory drug, is widely used for induction
of ulcers in animal research. These drugs are known to
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Figure 4: Effect of the p.o. administration of ethanolic extract of
geopropolis (EEGP) on the ethanol induced ulcers. Rats pretreated
with 5mg/kg of the indomethacin-INDO (i.p.). After 30min, the
rats were treated with vehicle (C and Indo) and 300mg/kg doses of
EEGP. The results are expressed as means ± SEM, 𝑛 = 5. Symbols
indicate statistical difference (ANOVA followed by Tukey test, 𝑃 <
0.05). # compared to control group; ∗ compared to control (C)
group; ∗∗ compared to EEGP group.
Table 1: Evaluation of the anti-secretory activity of the ethanolic
extract of geopropolis (EEGP) using the pyloric ligation model.
Means ± SEM, 𝑛 = 5.
Treatments Dose (mg/kg) Volume (mL) pH
Control — 3.3 ± 0.6 3.4 ± 0.5
Cimetidine 100 1.9 ± 0.3∗ 6.4 ± 0.1∗
EEGP 300 2.6 ± 0.5 3.4 ± 0.5
∗Compared to control group (ANOVA followed by Dunnett, 𝑃 < 0.05).
inhibit the production of prostaglandins, including those
that have protective action in the gastric tissue [27, 28]. The
prostaglandins produced in the stomach exert gastroprotec-
tive activity through the stimulatory action of the gastric
mucus and of bicarbonate secretion [29]. According to the
results (Figure 4), it was found that the prior administration
of indomethacin in ulcer model induced by ethanol reverted
the EEGP gastroprotective activity (𝑃 < 0.05). These results
suggest that the EEGP beyond develops its gastroprotective
activity through modulation of nitric oxide and also acts by
increasing the levels of prostaglandins present in the gastric
mucosa.
Finally, we evaluated the antisecretory activity of the
EEGP. Acetylcholine, histamine, and gastrin are endogenous
substances responsible for the regulation of acid secretion
[30]. Currently, antiulcer drugs act by blocking the acid
secretion, for example, omeprazole (proton pump blockers)
and cimetidine (H
2
inhibitor) [31].
The model of ligature of the pylorus of the stomach in
mice is widely used to study the antisecretory activity of
new drugs. This fact is understandable due to the effect
generated by ligation of the pylorus, which is the acids
hypersecretion on stomach [20]. According to Table 1, it is
observed that the volume and pH of gastric juice remained
unaltered in the stomachs of animals submitted to binding
the pylorus remained (𝑃 > 0.05), after administration of
EEGP (300mg/kg). On the other hand the positive control
(cimetidine 100mg/kg) not only decreased the gastric juice
volume, but also increased the pH (𝑃 < 0.05). These results,
therefore, suggest that the gastroprotective activity of the
EEGP is not related to the regulation of gastric secretion.
4. Conclusion
The results of this study indicate that geopropolis exerts a
gastroprotective effect in rats with ethanol-induced gastric
mucosal damage. The results also suggest that the gastropro-
tective effect of geopropolis could be related to the gastropro-
tective mechanism in which nitric oxide and prostaglandins
are involved.
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